Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2016 (2016), Article ID 7937385, 9 pages
http://dx.doi.org/10.1155/2016/7937385
Research Article

Preventive Effect of Dihydromyricetin against Cisplatin-Induced Nephrotoxicity In Vitro and In Vivo

1Center for Stem Cell & Regenerative Medicine, The Second Hospital of Shandong University, Jinan 250012, China
2Department of Joint Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong 250021, China

Received 15 April 2016; Accepted 27 July 2016

Academic Editor: Roberto K. N. Cuman

Copyright © 2016 Fei Wu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Pabla and Z. Dong, “Cisplatin nephrotoxicity: mechanisms and renoprotective strategies,” Kidney International, vol. 73, no. 9, pp. 994–1007, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Wang and S. J. Lippard, “Cellular processing of platinum anticancer drugs,” Nature Reviews Drug Discovery, vol. 4, no. 4, pp. 307–320, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G.-S. Oh, H.-J. Kim, A. Shen et al., “Cisplatin-induced kidney dysfunction and perspectives on improving treatment strategies,” Electrolyte and Blood Pressure, vol. 12, no. 2, pp. 55–65, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Arany and R. L. Safirstein, “Cisplatin nephrotoxicity,” Seminars in Nephrology, vol. 23, no. 5, pp. 460–464, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. X. Yao, K. Panichpisal, N. Kurtzman, and K. Nugent, “Cisplatin nephrotoxicity: a review,” The American Journal of the Medical Sciences, vol. 334, no. 2, pp. 115–124, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Beyer, O. Rick, S. Weinknecht, D. Kingreen, K. Lenz, and W. Siegert, “Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome,” Bone Marrow Transplantation, vol. 20, no. 10, pp. 813–819, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Y. Park, D. Lee, H.-J. Jang et al., “Protective effect of Artemisia asiatica extract and its active compound eupatilin against cisplatin-induced renal damage,” Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 483980, 6 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. T. K. Hyun, S. H. Eom, C. Y. Yu, and T. Roitsch, “Hovenia dulcis—an Asian traditional herb,” Planta Medica, vol. 76, no. 10, pp. 943–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Hou, Q. Tong, W. Wang, W. Xiong, C. Shi, and J. Fang, “Dihydromyricetin protects endothelial cells from hydrogen peroxide-induced oxidative stress damage by regulating mitochondrial pathways,” Life Sciences, vol. 130, Article ID 14330, pp. 38–46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. Y.-S. Zhang, Z.-X. Ning, S.-Z. Yang, and H. Wu, “Antioxidation properties and mechanism of action of dihydromyricetin from Ampelopsis grossedentata,” Yao Xue Xue Bao, vol. 38, no. 4, pp. 241–244, 2003. View at Google Scholar · View at Scopus
  11. S. Wu, B. Liu, Q. Zhang et al., “Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma HepG2 cells,” PLoS ONE, vol. 8, no. 11, Article ID e76886, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Ye, Y. Guan, S. Zeng, and D. Liu, “Ampelopsin prevents apoptosis induced by H2O2 in MT-4 lymphocytes,” Planta Medica, vol. 74, no. 3, pp. 252–257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Zhu, P. Luo, Y. Fu et al., “Dihydromyricetin prevents cardiotoxicity and enhances anticancer activity induced by adriamycin,” Oncotarget, vol. 6, no. 5, pp. 3254–3267, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Liu, D. N. Grigoryev, M. T. Crow et al., “Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice,” Kidney International, vol. 76, no. 3, pp. 277–285, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Lieberthal, V. Triaca, and J. Levine, “Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis,” American Journal of Physiology, vol. 270, no. 4, pp. F700–F708, 1996. View at Google Scholar · View at Scopus
  16. S. Li, A. Basnakian, R. Bhatt et al., “ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G,” American Journal of Physiology—Renal Physiology, vol. 287, pp. F990–F998, 2004. View at Google Scholar
  17. Q. Wei, G. Dong, J. Franklin, and Z. Dong, “The pathological role of Bax in cisplatin nephrotoxicity,” Kidney International, vol. 72, no. 1, pp. 53–62, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Baliga, N. Ueda, P. D. Walker, and S. V. Shah, “Oxidant mechanisms in toxic acute renal failure,” Drug Metabolism Reviews, vol. 31, no. 4, pp. 971–997, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. H. S. Lee, B. K. Kim, Y. Nam et al., “Protective role of phosphatidylcholine against cisplatin-induced renal toxicity and oxidative stress in rats,” Food and Chemical Toxicology, vol. 58, pp. 388–393, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. R. P. Miller, R. K. Tadagavadi, G. Ramesh, and W. B. Reeves, “Mechanisms of cisplatin nephrotoxicity,” Toxins, vol. 2, no. 11, pp. 2490–2518, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Kimura, T. Nojiri, H. Hosoda et al., “Protective effects of C-type natriuretic peptide on cisplatin-induced nephrotoxicity in Mice,” Cancer Chemotherapy and Pharmacology, vol. 75, no. 5, pp. 1057–1063, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. P. J. Loehrer and L. H. Einhorn, “Drugs five years later. Cisplatin,” Annals of Internal Medicine, vol. 100, no. 5, pp. 704–713, 1984. View at Publisher · View at Google Scholar · View at Scopus
  23. J.-Y. Xu, Q.-H. Meng, Y. Chong et al., “Sanguinarine inhibits growth of human cervical cancer cells through the induction of apoptosis,” Oncology Reports, vol. 28, no. 6, pp. 2264–2270, 2012. View at Publisher · View at Google Scholar · View at Scopus